The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,642
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855
The asialoglycoprotein receptor: relationships between structure, function, and expression
Stockert, R. J. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.591 · Cited by 520
Age-related changes in liver structure and function: Implications for disease ?
Schmucker, D. L. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.009 · Cited by 481
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment
Chung, T. W., Yang, J., Akaike, T., Cho, K. Y., Nah, J. W., Kim, S. I., & Cho, C. S. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00399-4 · Cited by 371
Schwartz, A. L., Fridovich, S. E., & Lodish, H. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34710-0 · Cited by 364
Research works printed but not linked: 62
- Dodeur, 1982, Effects of streptozotocin-induced diabetes mellitus on the binding and uptake of asialoorosomucoid by isolated hepatocytes from rats, Eur. J. Biochem., 123, 383, 10.1111/j.1432-1033.1982.tb19780.x · doi:10.1111/j.1432-1033.1982.tb19780.x
- Kawakami, 2002, Glycosylated cationic liposomes for cell-selective gene delivery, Crit. Rev. Ther. Drug Carrier Syst., 19, 171, 10.1615/CritRevTherDrugCarrierSyst.v19.i2.30 · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.30
- Wong, 1987, Synthesis of D-galactosamine derivatives and binding studies using isolated rat hepatocytes, Carbohydr. Res., 170, 27, 10.1016/0008-6215(87)85003-6 · doi:10.1016/0008-6215(87)85003-6
- Lee, 2011, New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes, Bioorg. Med. Chem., 19, 2494, 10.1016/j.bmc.2011.03.027 · doi:10.1016/j.bmc.2011.03.027
- McAbee, 1999, Copper and zinc ions differentially block asialoglycoprotein receptor-mediated endocytosis in isolated rat hepatocytes, J. Biol. Chem., 274, 14750, 10.1074/jbc.274.21.14750 · doi:10.1074/jbc.274.21.14750
- Kim, 2006, Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan, Nucl. Med. Biol., 33, 529, 10.1016/j.nucmedbio.2006.03.005 · doi:10.1016/j.nucmedbio.2006.03.005
- Debanne, 1982, Receptor-rich intracellular membrane vesicles transporting asialotransferrin and insulin in liver, Nature, 298, 398, 10.1038/298398a0 · doi:10.1038/298398a0
- Fiume, 1997, Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-ʟ-lysine. Synthesis of the carrier and pharmacological properties of the conjugate, J. Hepatol., 26, 253, 10.1016/S0168-8278(97)80038-4 · doi:10.1016/s0168-8278(97)80038-4
- Regoeczi, 1978, Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism, Biochim. Biophys. Acta, 541, 372, 10.1016/0304-4165(78)90196-4 · doi:10.1016/0304-4165(78)90196-4
- Kaneo, 2000, Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats, Int. J. Pharm., 201, 59, 10.1016/S0378-5173(00)00405-1 · doi:10.1016/s0378-5173(00)00405-1
- Bertoldo, 2004, Cloning, sequencing, and characterization of a heat- and alkali-stable type I pullulanase from Anaerobranca gottschalkii, Appl. Environ. Microbiol., 70, 3407, 10.1128/AEM.70.6.3407-3416.2004 · doi:10.1128/aem.70.6.3407-3416.2004
- Gupta, 2004, In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system, J. Pharm. Pharm. Sci., 7, 38
- Tanaka, 2005, Uptake of pullulan in cultured rat liver parenchymal cells, Biol. Pharm. Bull., 28, 560, 10.1248/bpb.28.560 · doi:10.1248/bpb.28.560
- San Juan, 2007, Cationized pullulan 3D matrices as new materials for gene transfer, J. Biomed. Mater. Res. A, 82, 354, 10.1002/jbm.a.31062 · doi:10.1002/jbm.a.31062
- Yim, 2011, The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI, Biomaterials, 32, 5187, 10.1016/j.biomaterials.2011.03.069 · doi:10.1016/j.biomaterials.2011.03.069
- Shimizu, 1997, Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting, Biol. Pharm. Bull., 20, 881, 10.1248/bpb.20.881 · doi:10.1248/bpb.20.881
- Ghiamkazemi, 2010, Synthesis, and characterization, and evaluation of cellular effects of the FOL-PEG-g-PEI-GAL nanoparticles as a potential non-viral vector for gene delivery, J. Nanomater., 10
- Meng, 2005, Immobilization of lactobionic acid on polyurethane films and their interaction with hepatocytes, Macromol. Res., 13, 257, 10.1007/BF03219061 · doi:10.1007/bf03219061
- Qin, 2011, Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers, Bioconjug. Chem., 22, 1503, 10.1021/bc100525y · doi:10.1021/bc100525y
- Shigeta, 2007, Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells, J. Control. Release, 118, 262, 10.1016/j.jconrel.2006.12.019 · doi:10.1016/j.jconrel.2006.12.019
- Suginoshita, 2002, Liver targeting of human interferon-beta with pullulan based on metal coordination, J. Control. Release, 83, 75, 10.1016/S0168-3659(02)00197-9 · doi:10.1016/s0168-3659(02)00197-9
- Di Stefano, 2000, Enhanced liver blood concentrations of adenine arabinoside accomplished by lactosaminated poly-ʟ-lysine coupling: implications for regional chemotherapy of hepatic micrometastases, Biochem. Pharmacol., 59, 301, 10.1016/S0006-2952(99)00327-5 · doi:10.1016/s0006-2952(99)00327-5
- Peng, 2007, Inhibition of hepatocarcinoma by systemic delivery of apoptin gene via the hepatic asialoglycoprotein receptor, Cancer Gene Ther., 14, 66, 10.1038/sj.cgt.7700985 · doi:10.1038/sj.cgt.7700985
- Tomiya, 2013, Liver-targeting of primaquine-(poly-gamma-glutamic acid) and its degradation in rat hepatocytes, Bioorg. Med. Chem., 21, 5275, 10.1016/j.bmc.2013.06.028 · doi:10.1016/j.bmc.2013.06.028
- Fiume, 1984, Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver, Gut, 25, 1392, 10.1136/gut.25.12.1392 · doi:10.1136/gut.25.12.1392
- Naicker, 2014, PEGylated galactosylated cationic liposomes for hepatocytic gene delivery, Colloids Surf. B: Biointerfaces, 122, 482, 10.1016/j.colsurfb.2014.07.010 · doi:10.1016/j.colsurfb.2014.07.010
- Weigel, 1980, Characterization of the asialoglycoprotein receptor on isolated rat hepatocytes, J. Biol. Chem., 255, 6111, 10.1016/S0021-9258(18)43708-8 · doi:10.1016/s0021-9258(18)43708-8
- Kawakami, 2001, Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs, J. Pharm. Sci., 90, 105, 10.1002/1520-6017(200102)90:2<105::AID-JPS1>3.0.CO;2-1 · doi:10.1002/1520-6017(200102)90:2<105::aid-jps1>3.0.co;2-1
- Hara, 1996, Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes, Biochim. Biophys. Acta, 1278, 51, 10.1016/0005-2736(95)00205-7 · doi:10.1016/0005-2736(95)00205-7
- Tep, 2009, Formulation and evaluation of ATP-containing liposomes including lactosylated ASGPr ligand, J. Liposome Res., 19, 287, 10.3109/08982100902838682 · doi:10.3109/08982100902838682
- Hai, 2010, Synthesis of multivalent galactosides as targeting ligand for gene delivery, Synth. Commun., 40, 1802, 10.1080/00397910903161827 · doi:10.1080/00397910903161827
- Narainpersad, 2012, Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2, Nucleosides Nucleotides Nucleic Acids, 31, 206, 10.1080/15257770.2011.649331 · doi:10.1080/15257770.2011.649331
- Sun, 2005, Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD), J. Drug Target., 13, 121, 10.1080/10611860400024714 · doi:10.1080/10611860400024714
- Zhu, 2013, Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate, Int. J. Mol. Sci., 14, 15755, 10.3390/ijms140815755 · doi:10.3390/ijms140815755
- Jain, 2010, Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin, AAPS PharmSciTech, 11, 686, 10.1208/s12249-010-9422-z · doi:10.1208/s12249-010-9422-z
- Varshosaz, 2012, Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma, J. Liposome Res., 22, 224, 10.3109/08982104.2012.662653 · doi:10.3109/08982104.2012.662653
- Lu, 2008, The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice, Int. J. Biol. Macromol., 43, 320, 10.1016/j.ijbiomac.2008.06.006 · doi:10.1016/j.ijbiomac.2008.06.006
- Joshi, 2014, Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand, Drug Deliv. Transl. Res., 4, 353, 10.1007/s13346-014-0200-4 · doi:10.1007/s13346-014-0200-4
- Managit, 2005, Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells, Int. J. Pharm., 301, 255, 10.1016/j.ijpharm.2005.05.020 · doi:10.1016/j.ijpharm.2005.05.020
- Hattori, 2000, Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting, J. Control. Release, 69, 369, 10.1016/S0168-3659(00)00338-2 · doi:10.1016/s0168-3659(00)00338-2
- Ishida, 2004, Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice, Pharm. Res., 21, 932, 10.1023/B:PHAM.0000029280.39882.ff · doi:10.1023/b:pham.0000029280.39882.ff
- Motoyama, 2011, In vitro gene delivery mediated by lactosylated dendrimer (generation 3, G3)/α-cyclodextrin conjugates into hepatocytes, J. Incl. Phenom. Macrocycl. Chem., 70, 333, 10.1007/s10847-010-9842-0 · doi:10.1007/s10847-010-9842-0
- Wang, 2009, Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon, Hepatology, 50, 815, 10.1002/hep.23060 · doi:10.1002/hep.23060
- Hohokabe, 2007, Hepatocyte-selective gene transfer by galactosylated protein/linear polyethyleneimine/plasmid DNA complexes in mice, J. Biomed. Nanotechnol., 3, 277, 10.1166/jbn.2007.034 · doi:10.1166/jbn.2007.034
- Hwang, 1999, Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT, J. Nucl. Med., 40, 1644
- Iimuro, 2010, Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters, J. Hepatobiliary Pancreat. Sci., 17, 673, 10.1007/s00534-010-0264-6 · doi:10.1007/s00534-010-0264-6
- Kaibori, 2011, Usefulness of Tc-99m-GSA scintigraphy for liver surgery, Ann. Nucl. Med., 25, 593, 10.1007/s12149-011-0520-0 · doi:10.1007/s12149-011-0520-0
- Haubner, 2013, Development of (6)(8)Ga-labelled DTPA galactosyl human serum albumin for liver function imaging, Eur. J. Nucl. Med. Mol. Imaging, 40, 1245, 10.1007/s00259-013-2397-8 · doi:10.1007/s00259-013-2397-8
- Yoshinori, 2010, Molecular imaging contrast media for visualization of liver function, Magn. Reson. Imaging, 28, 708, 10.1016/j.mri.2010.02.003 · doi:10.1016/j.mri.2010.02.003
- Deal, 1998, Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver, Nucl. Med. Biol., 25, 379, 10.1016/S0969-8051(97)00222-9 · doi:10.1016/s0969-8051(97)00222-9
- Ogawara, 1998, Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver, J. Control. Release, 50, 309, 10.1016/S0168-3659(97)00157-0 · doi:10.1016/s0168-3659(97)00157-0
- Ha-Kawa, 1997, Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study, Eur. J. Nucl. Med., 24, 130, 10.1007/BF02439544 · doi:10.1007/bf02439544
- Yang, 2013, The preparation of 99mTc-DTPA-LSA and its instant lyophilized kit for hepatic receptor imaging, Appl. Radiat. Isot., 74, 1, 10.1016/j.apradiso.2012.12.009 · doi:10.1016/j.apradiso.2012.12.009
- Richard, 2009, Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging, Int. J. Pharm., 379, 301, 10.1016/j.ijpharm.2009.05.045 · doi:10.1016/j.ijpharm.2009.05.045
- Ketkar-Atre, 2014, In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes, Biomaterials, 35, 1015, 10.1016/j.biomaterials.2013.10.029 · doi:10.1016/j.biomaterials.2013.10.029
- Hausdorf, 2009, Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA—revival of a disease-activity marker in autoimmune hepatitis, Clin. Chim. Acta, 408, 19, 10.1016/j.cca.2009.06.035 · doi:10.1016/j.cca.2009.06.035
- Ise, 2001, Separation of mouse hepatocytes of distinct biological phenotypes based on their asialoglycoprotein receptor-mediated adhesion to an artificial ligand, J. Artif. Organs, 4, 342, 10.1007/BF02480029 · doi:10.1007/bf02480029
- Yura, 2009, Coatings of low-density lipoprotein and synthetic glycoconjugates as substrata for hepatocytes, Artif. Organs, 33, 419, 10.1111/j.1525-1594.2009.00746.x · doi:10.1111/j.1525-1594.2009.00746.x
- Chernyy, 2013, Surface grafted glycopolymer brushes to enhance selective adhesion of HepG2 cells, J. Colloid Interface Sci., 404, 207, 10.1016/j.jcis.2013.04.025 · doi:10.1016/j.jcis.2013.04.025
- Matsuzaki, 1997, Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve, Hepatology, 25, 828, 10.1002/hep.510250407 · doi:10.1002/hep.510250407
- DiStefano, 2006, Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas, Dig. Liver Dis., 38, 2
- Dong, 2008, Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo, J. Biomed. Mater. Res. A, 84, 777, 10.1002/jbm.a.31328 · doi:10.1002/jbm.a.31328
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Crooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics
Springer, A. D., & Dowdy, S. F. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0736 · Cited by 711
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Shen, X., & Corey, D. R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 632
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Oliveri, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841814 · Cited by 367
Carbohydrate-Based Macromolecular Biomaterials
Su, L., Feng, Y., Wei, K., Xu, X., Liu, R., & Chen, G. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01338 · Cited by 335
Lipid-based nanoparticle technologies for liver targeting
Böttger, R., Pauli, G., Chao, P.-H., AL Fayez, N., Hohenwarter, L., & Li, S.-D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.017 · Cited by 264
RNA therapy: rich history, various applications and unlimited future prospects
Kim, Y.-K. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00757-5 · Cited by 264
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Shivatare, S. S., Shivatare, V. S., & Wong, C.-H. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 257
Bifunctional small molecules that mediate the degradation of extracellular proteins
Caianiello, D. F., Zhang, M., Ray, J. D., Howell, R. A., Swartzel, J. C., Branham, E. M. J., Chirkin, E., Sabbasani, V. R., Gong, A. Z., McDonald, D. M., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00851-1 · Cited by 244
Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
Rouet, R., Thuma, B. A., Roy, M. D., Lintner, N. G., Rubitski, D. M., Finley, J. E., Wisniewska, H. M., Mendonsa, R., Hirsh, A., de Oñate, L., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01551 · Cited by 163
Nakamura, T., Sato, Y., Yamada, Y., Abd Elwakil, M. M., Kimura, S., Younis, M. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114417 · Cited by 121
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
Katzmann, J. L., Packard, C. J., Chapman, M. J., Katzmann, I., & Laufs, U. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.070 · Cited by 99
Chemical modification of the adeno-associated virus capsid to improve gene delivery
Mével, M., Bouzelha, M., Leray, A., Pacouret, S., Guilbaud, M., Penaud-Budloo, M., Alvarez-Dorta, D., Dubreil, L., Gouin, S. G., Combal, J. P., et al. (2020) · Chemical Science · doi:10.1039/c9sc04189c · Cited by 92
Targeted Drug Delivery via the Use of ECM-Mimetic Materials
Hwang, J., Sullivan, M. O., & Kiick, K. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00069 · Cited by 76
Oral lipid nanomedicines: Current status and future perspectives in cancer treatment
El Moukhtari, S. H., Rodríguez-Nogales, C., & Blanco-Prieto, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.004 · Cited by 70
Liu, W., Zhu, Y., Wang, F., Li, X., Liu, X., Pang, J., & Pan, W. (2018) · Royal Society Open Science · doi:10.1098/rsos.181027 · Cited by 59
Hepatocyte targeting via the asialoglycoprotein receptor
Ramírez-Cortés, F., & Ménová, P. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00652f · Cited by 55
Ebenezer, O., Comoglio, P., Wong, G. K.-S., & Tuszynski, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044019 · Cited by 39
GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases
Qin, Z.-X., Zuo, L., Zeng, Z., Ma, R., Xie, W., Zhu, X., & Zhou, X. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2466767 · Cited by 32
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Gjølberg, T. T., Mester, S., Calamera, G., Telstad, J. S., Sandlie, I., & Andersen, J. T. (2025) · BioDrugs · doi:10.1007/s40259-025-00708-2 · Cited by 20
Piotrowska, U., Szatko, J., Nowakowska, A., Klimaszewska, E., Ogorzałek, M., & Sobczak, M. (2025) · Marine Drugs · doi:10.3390/md23120467 · Cited by 14
Kim, S., Lee, D. H., Park, H. W., Noh, K. M., Jangid, A. K., Park, H., Kim, G. J., & Kim, K. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.158313 · Cited by 11
Metadata
- Authors
- D'Souza, A. A., & Devarajan, P. V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 203
- Pages
- 126-139
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2052108548
- Cited by
- 621
- References
- 183
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.